Russia Covid Vaccine Trial
- All
- News
- Videos
-
Vladimir Putin Says He Took Part In Trials Of Nasal Form Of Covid Vaccine
Russia said on Wednesday it planned to export a nasal form of its Sputnik vaccine against COVID-19, which President Vladimir Putin said he had taken as a booster.
-
Russian Covid Vaccine In Phase 3 Trial, To Cost Less Than $10 Per Dose In India
The Russian COVID-19 vaccine "Sputnik V" will cost less than USD 10 (about Rs 730) per shot in India and the price is the same for all countries, Kirill Dmitriev, CEO of Russian Direct Investment Fund (RDIF) said on Thursday.
-
"When Is India's Turn, Modi Ji?": Rahul Gandhi's Jibe Over Covid Vaccine
Congress's Rahul Gandhi today aimed a jibe at Prime Minister Narendra Modi, pointing to several nations beginning inoculation for Covid and implying India's journey towards a vaccine is slow. Four nations -- US, UK, China and Russia -- are pressing ahead with vaccination as a new, more infectious mutation of the virus has brought life to a standsti...
-
Russia's Covid Vaccine Sputnik Shows 91.4% Efficacy In New Trial: Report
Russian coronavirus vaccine developers published fresh results from their trial of the Sputnik V vaccine on Monday based on new data, and said the shot had again been found to be 91.4 per cent effective in providing protection from COVID-19.
-
Russia Covid Vaccine May Reach Kanpur Next Week For Phase-2 Trial: Report
The first batch of Russia's Sputnik V vaccine for COVID-19 is likely to reach Kanpur's Ganesh Shankar Vidyarthi Medical College by next week wherein the vaccine's Phase 2 and Phase 3 human clinical trials will be conducted.
-
Russia Says Sputnik V Vaccine 92% Effective Against Coronavirus
Russia's Sputnik V vaccine is 92% effective at protecting people from COVID-19 according to interim trial results, the country's sovereign wealth fund said on Wednesday, as Moscow rushes to keep pace with Western drugmakers in the race for a shot.
-
Dr. Reddy's Shuts Key Plans, Isolates Data Centre Services After Cyberattack
Pharmaceutical giant Dr. Reddy's Laboratories today said that it had isolated all its data centre services as a preventive measure following a cyberattack. The drug maker had shut its key plants globally due to the breach at its servers, ET Now had reported, citing sources.
-
Russia Approves Second Covid Vaccine After Preliminary Trials
Russia has granted regulatory approval to a second COVID-19 vaccine, according to its register of authorised medicines.
-
Dr Reddy's Reapplies For Clinical Trials Of Russian Covid Vaccine: Report
The Hyderabad-based Dr Reddy's Laboratories has reapplied to the Drugs Controller General of India (DCGI) seeking permission to conduct combined phases 2 and 3 human clinical trials of the Russian COVID-19 vaccine Sputnik V in India.
-
UAE To Host Second Human Trial Abroad Of Russia's COVID-19 Vaccine Sputnik V
Human trials of Russia's COVID-19 vaccine, named Sputnik V, will be held in the United Arab Emirates, the second country after Belarus to take part in the programme of which results are expected before the end of November, Moscow said on Monday.
-
Vladimir Putin Says He Took Part In Trials Of Nasal Form Of Covid Vaccine
Russia said on Wednesday it planned to export a nasal form of its Sputnik vaccine against COVID-19, which President Vladimir Putin said he had taken as a booster.
-
Russian Covid Vaccine In Phase 3 Trial, To Cost Less Than $10 Per Dose In India
The Russian COVID-19 vaccine "Sputnik V" will cost less than USD 10 (about Rs 730) per shot in India and the price is the same for all countries, Kirill Dmitriev, CEO of Russian Direct Investment Fund (RDIF) said on Thursday.
-
"When Is India's Turn, Modi Ji?": Rahul Gandhi's Jibe Over Covid Vaccine
Congress's Rahul Gandhi today aimed a jibe at Prime Minister Narendra Modi, pointing to several nations beginning inoculation for Covid and implying India's journey towards a vaccine is slow. Four nations -- US, UK, China and Russia -- are pressing ahead with vaccination as a new, more infectious mutation of the virus has brought life to a standsti...
-
Russia's Covid Vaccine Sputnik Shows 91.4% Efficacy In New Trial: Report
Russian coronavirus vaccine developers published fresh results from their trial of the Sputnik V vaccine on Monday based on new data, and said the shot had again been found to be 91.4 per cent effective in providing protection from COVID-19.
-
Russia Covid Vaccine May Reach Kanpur Next Week For Phase-2 Trial: Report
The first batch of Russia's Sputnik V vaccine for COVID-19 is likely to reach Kanpur's Ganesh Shankar Vidyarthi Medical College by next week wherein the vaccine's Phase 2 and Phase 3 human clinical trials will be conducted.
-
Russia Says Sputnik V Vaccine 92% Effective Against Coronavirus
Russia's Sputnik V vaccine is 92% effective at protecting people from COVID-19 according to interim trial results, the country's sovereign wealth fund said on Wednesday, as Moscow rushes to keep pace with Western drugmakers in the race for a shot.
-
Dr. Reddy's Shuts Key Plans, Isolates Data Centre Services After Cyberattack
Pharmaceutical giant Dr. Reddy's Laboratories today said that it had isolated all its data centre services as a preventive measure following a cyberattack. The drug maker had shut its key plants globally due to the breach at its servers, ET Now had reported, citing sources.
-
Russia Approves Second Covid Vaccine After Preliminary Trials
Russia has granted regulatory approval to a second COVID-19 vaccine, according to its register of authorised medicines.
-
Dr Reddy's Reapplies For Clinical Trials Of Russian Covid Vaccine: Report
The Hyderabad-based Dr Reddy's Laboratories has reapplied to the Drugs Controller General of India (DCGI) seeking permission to conduct combined phases 2 and 3 human clinical trials of the Russian COVID-19 vaccine Sputnik V in India.
-
UAE To Host Second Human Trial Abroad Of Russia's COVID-19 Vaccine Sputnik V
Human trials of Russia's COVID-19 vaccine, named Sputnik V, will be held in the United Arab Emirates, the second country after Belarus to take part in the programme of which results are expected before the end of November, Moscow said on Monday.
